Serotype distribution and antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates among adult and elderly population before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco

被引:2
|
作者
Nzoyikorera, Nehemie [1 ,2 ,3 ,4 ]
Diawara, Idrissa [2 ,3 ]
Katfy, Mostafa [1 ,5 ]
Katfy, Khalid [1 ,5 ]
Maaloum, Fakhreddine [1 ]
Nyandwi, Joseph [6 ,7 ]
Belabbes, Houria [1 ,5 ]
Elmdaghri, Naima [1 ,5 ]
Zerouali, Khalid [1 ,5 ]
机构
[1] Hassan II Univ Casablanca, Fac Med & Pharm Casablanca, Dept Microbiol, Casablanca, Morocco
[2] Mohammed VI Univ Hlth Sci UM6SS, Higher Inst Biosci & Biotechnol, Casablanca, Morocco
[3] Mohammed VI Univ Hlth Sci UM6SS, Mohammed Ctr Res & Innovat 6, Lab Microbial Biotechnol & Infectiol Res, Casablanca, Morocco
[4] Natl Inst Publ Hlth, Natl Reference Lab, Bujumbura, Burundi
[5] Ibn Rochd Univ Hosp Ctr Casablanca, Bacteriol Virol & Hosp Hyg Lab, Casablanca, Morocco
[6] Univ Burundi, Fac Med, Dept Med, Bujumbura, Burundi
[7] Inst Natl St Publ Bujumbura, Minist St Publ & Lutte Sida, Bujumbura, Burundi
关键词
Streptococcus pneumoniae; Serotype; Antibiotic resistance; Invasive pneumococcal diseases; Adult population; Herd effect; Pneumococcal conjugate vaccine; ANTIBIOTIC-RESISTANCE; DISEASE; EPIDEMIOLOGY; SURVEILLANCE; STRAINS; SOUTH;
D O I
10.1186/s12879-023-07981-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundStreptococcus pneumoniae (S. pneumoniae), remains a major cause of mortality and morbidity worldwide. The objective of this study was to determine the trends of invasive pneumococcal diseases (IPD) in adult and elderly population in Casablanca (Morocco) before and after introduction of pneumococcal conjugate vaccine (PCV) by determining the distribution of pneumococcal serotypes and antibiotic resistance profile of isolated strains.MethodThe proposed study is a retrospective laboratory-based surveillance of IPD in hospitalized adult (15-59 years old) and elderly (>= 60 years old) patients in Ibn Rochd University Hospital Centre from 2007 to 2019 (13 years). All the 250 non-duplicate clinical invasive isolates from adult and elderly patients, confirmed as S. pneumoniae according to the laboratory standard identification procedures, are included in this study.ResultsA significant decrease of the overall incidence in IPD was observed only in adults from 0.71 to 0.54/100000 populations (P = 0.02) and to 0.47/100000 populations (P = 0.0137) in the early and mature post-vaccine period respectively compared to the pre-vaccine period. Our results also showed a significant reduction in the overall prevalence of vaccine serotypes from 28.17 to 6.90% (P = 0.0021) for the PCV-10 serotypes, and from 46.48 to 25.86% (P = 0.0164) for the PCV-13 serotypes only in the mature post-vaccine period (2015-2019). In parallel, the rate of non-vaccine serotypes did not significantly change in the early post-vaccine period (2011-2014) while it increased considerably from 54 to 74.14% (P = 0.0189) during the mature post-vaccine period. The rate of penicillin non-susceptible pneumococcal isolates decreased significantly from 23.94 to 8.77% (P = 0.02) in adult patients, and the rate of cotrimoxazole non-susceptible pneumococcal isolates significantly decreased from 29.58 to 8.77% in the early post-vaccine period (P = 0.003) and to 7.24% in the mature post-vaccine period (P = 0.0007).ConclusionAlthough childhood vaccination has considerably reduced the incidence of IPD in adult population through the herd effect, IPD remain a real public health problem due to the alarming increase in non-vaccine serotypes (NVS) and the lack of herd effect among elderly population. The rate of antibiotic resistance was relatively low. Nevertheless, resistance constitutes a serious problem to the therapeutic arsenal due to the known capacity for genetic dissemination in the pneumococcus.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010
    Demczuk, Walter H. B.
    Martin, Irene
    Griffith, Averil
    Lefebvre, Brigitte
    McGeer, Allison
    Shane, Amanda
    Zhanel, George G.
    Tyrrell, Gregory J.
    Gilmour, Matthew W.
    CANADIAN JOURNAL OF MICROBIOLOGY, 2012, 58 (08) : 1008 - 1017
  • [22] Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005
    Messina, Allison F.
    Katz-Gaynor, Kathy
    Barton, Theresa
    Ahmad, Naveed
    Ghaffar, Faryal
    Rasko, David
    McCracken, George H., Jr.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (06) : 461 - 467
  • [23] Impact of the pneumococcal conjugate vaccine on serotype distribution of adult non-invasive Streptococcus pneumoniae isolates in Tokai region, Japan, 2008-2016
    Furuya, Yuri
    Yamagishi, Yuka
    Okade, Hayato
    Kadota, Takumi
    Funatsu, Tori
    Eto, Maki
    Nomura, Nobuhiko
    Mitsuyama, Junichi
    Mikamo, Hiroshige
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2017, 23 (5-6) : 394 - 399
  • [24] Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolates among children in Suzhou, China
    Dai, Ge
    Wang, Ting
    He, Yuting
    Jiang, Wujun
    Sun, Huiming
    Chen, Zhengrong
    Zhang, Tao
    Yan, Yongdong
    TRANSLATIONAL PEDIATRICS, 2023, 12 (12) : 2203 - 2212
  • [25] Antimicrobial Resistance among Isolates Causing Invasive Pneumococcal Disease before and after Licensure of Heptavalent Conjugate Pneumococcal Vaccine
    Karnezis, Tom Theodore
    Smith, Ann
    Whittier, Susan
    Haddad, Joseph, Jr.
    Saiman, Lisa
    PLOS ONE, 2009, 4 (06):
  • [26] Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil
    Brandileone, Maria-Cristina C.
    Almeida, Samanta C. G.
    Minamisava, Ruth
    Andrade, Ana-Lucia
    VACCINE, 2018, 36 (19) : 2559 - 2566
  • [27] Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine
    Poehling, KA
    Talbot, TR
    Griffin, MR
    Craig, AS
    Whitney, CG
    Zell, E
    Lexau, CA
    Thomas, AR
    Harrison, LH
    Reingold, AL
    Hadler, JL
    Farley, MM
    Anderson, BJ
    Schaffner, W
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (14): : 1668 - 1674
  • [28] High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
    Todd D. Swarthout
    Claudio Fronterre
    José Lourenço
    Uri Obolski
    Andrea Gori
    Naor Bar-Zeev
    Dean Everett
    Arox W. Kamng’ona
    Thandie S. Mwalukomo
    Andrew A. Mataya
    Charles Mwansambo
    Marjory Banda
    Sunetra Gupta
    Peter Diggle
    Neil French
    Robert S. Heyderman
    Nature Communications, 11
  • [29] Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the National Immunization Program
    Petrovic, Vladimir
    Seguljev, Zorica
    Ristic, Mioljub
    Djekic-Malbasa, Jelena
    Radosavljevic, Biljana
    Medic, Deana
    Mihajlovic-Ukropina, Mira
    Hadnadjev, Mirjana
    Gajic, Ina
    Opavski, Natasa
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2016, 144 (9-10) : 521 - 526
  • [30] High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
    Swarthout, Todd D.
    Fronterre, Claudio
    Lourenco, Jose
    Obolski, Uri
    Gori, Andrea
    Bar-Zeev, Naor
    Everett, Dean
    Kamng'ona, Arox W.
    Mwalukomo, Thandie S.
    Mataya, Andrew A.
    Mwansambo, Charles
    Banda, Marjory
    Gupta, Sunetra
    Diggle, Peter
    French, Neil
    Heyderman, Robert S.
    NATURE COMMUNICATIONS, 2020, 11 (01)